Epigenome and transcriptome editing


Genome editing refers to an emerging branch of biotechnology that is the realization of earlier genetic engineering technologies. Using these biotechnologies researchers are able to target specific DNA sequences and induce a double stranded break, taking advantage of recombination to create synthetic genetic content in a host genome.



 


  • Epigenome Editing
  • Artificial Transcription Factors (ATFs)
  • Activating Transcription
  • Repressing Transcription

Related Conference of Epigenome and transcriptome editing

September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

44th Euro Congress on Cancer Science & Therapy

Paris, France
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK

Epigenome and transcriptome editing Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in